
|Articles|March 1, 2001
- Pharmaceutical Executive-03-01-2001
- Volume 0
- Issue 0
Patents: China on the Genome Map
Author(s)Andra Brichacek
Beijing, China-Chinese scientists registered more than 110 patents on genes cloned last year from the human hypothalamus}pituitary}adrenal axis. They profiled the axis} gene expression, cloning more than 300 previously unknown genes discovered during its sequencing.
Advertisement
Articles in this issue
over 24 years ago
Research: New Horizonsover 24 years ago
Earnings: Tough Times Aheadover 24 years ago
Outbreak: Anthrax Alarmover 24 years ago
Privacy, Pediatrics, and Policyover 24 years ago
Lilly's International Familyover 24 years ago
Update: Punishment and Reprieveover 24 years ago
Shortage: Vaccine Worriesover 24 years ago
Gateway to Japanover 24 years ago
SurroundedNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Bayer’s Lynkuet as First Dual Neurokinin Antagonist for Menopausal Hot Flashes
2
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
3
FDA Approves Blenrep for Treatment of Replapsed/Refractory Multiple Myeloma
4
Pharmaceutical Executive Daily: TrumpRx's Implication on DTC Commercialization
5





